[Retracted] LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment

Qiumin Li, Ying Wang, Feifei Liu, Haili Wang, Yangyang Fan

Open source

DOI
10.1155/2022/1926605
Published
2022-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1926605,
  title = {[Retracted] LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment},
  author = {Qiumin Li and Ying Wang and Feifei Liu and Haili Wang and Yangyang Fan},
  year = {2022},
  journal = {BioMed Research International},
  doi = {10.1155/2022/1926605},
  url = {https://doi.org/10.1155/2022/1926605}
}

RIS

TY  - JOUR
TI  - [Retracted] LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment
AU  - Qiumin Li
AU  - Ying Wang
AU  - Feifei Liu
AU  - Haili Wang
AU  - Yangyang Fan
PY  - 2022
JO  - BioMed Research International
DO  - 10.1155/2022/1926605
UR  - https://doi.org/10.1155/2022/1926605
ER  - 

APA

Li, Q., Wang, Y., Liu, F., Wang, H., & Fan, Y. (2022). [Retracted] LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment. BioMed Research International. https://doi.org/10.1155/2022/1926605

Source records